348619-35-2

Upstream product

• 348617-45-8 7-chloro-6-nitro-4-(3,4,5-trimethoxyanilino)-3-quinolinecarbonitrile 
• 263149-40-2 4,7-dichloro-6-nitro-3-quinolinecarbonitrile 
• 825-41-2 3-chloro-4-nitroaniline 
• 348619-34-1 7-azido-6-nitro-4-(3,4,5-trimethoxyanilino)-3-quinolinecarbonitrile 
• 348617-31-2 7-chloro-6-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 
• 263149-39-9 7-chloro-6-nitro-4-oxo-1,4-dihydroquinoline-3-carbonitrile 
• 75001-52-4 7-chloro-6-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ethyl ester 
• 348617-32-3 7-chloro-6-nitro-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid amide 

Downstream Products

• 348617-61-8 2-(chloromethyl)-8-(3,4,5-trimethoxyanilino)imidazo[4,5-g]quinoline-7-carbonitrile 

Relevant academic research and scientific papers

8-Anilinoimidazo[4,5-g]quinoline-7-carbonitriles as Src kinase inhibitors

A series of 8-anilinoimidazo[4,5-g]quinoline-7-carbonitriles was synthesized and evaluated as Src kinase inhibitors. Several aniline substituents were surveyed, as well as water-solubilizing groups at the C-2 and N-3 positions. Potent Src inhibitors were

Tricyclic protein kinase inhibitors

This invention provides compounds of formula 1, having the structure which are useful as inhibitors of protein tyro sine kinase and are antiproliferative agents.